In this investigation, we examined the therapeutic advantage and the mechanism of Calebin A in the modulation of TNF-β-promoted inflammatory, pro-survival effects in colon cancer resistant and non-resistant cells to 5-FU and in promoting chemosensitization to 5-FU-induced anti-tumorigenic effects. The gene discussed is LTA; the disease is malignant colon neoplasm.